The cholangiopathies: disorders of biliary epithelia.
Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
Endoscopic management of bile duct stones; (apples and oranges).
Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database.
Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation".
Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver.
Major hepatic resection. A 25-year experience.
Autoimmune related pancreatitis.
Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities.
Foxa1 and Foxa2 regulate bile duct development in mice.
Pathophysiology of cholangiopathies.
Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation.
The pathobiology of biliary epithelia.
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.
Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video).
Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.